Lurker Nancy Insider Trades

Insider Trading History

Track insider trading activity for Lurker Nancy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alkermes plc
Alkermes plc ALKS
Director
Holding Value $876k 18,222 shares
Last Trade
May 21, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$54.5k 1,475 shares
$36.95
$48.07
Alkermes plc
Alkermes plc ALKS
Director
Holding Value $947k 19,697 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$227k 6,142 shares
$36.95
$48.07
Alkermes plc
Alkermes plc ALKS
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$227k 6,142 shares
$36.95
$48.07
Alkermes plc
Alkermes plc ALKS
Director
Holding Value $555k 11,538 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$627k 16,947 shares
$36.98
$48.07
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $926k 26,758 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$304k 8,741 shares
$34.83
$34.62
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $624k 18,017 shares
Last Trade
May 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$162k 4,500 shares
$35.97
$34.62
Alkermes plc
Alkermes plc ALKS
Director
Holding Value $180k 3,752 shares
Last Trade
Apr 11, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$125k 3,751 shares
$33.36
$48.07
Alkermes plc
Alkermes plc ALKS
Director
Holding Value $695k 14,456 shares
Last Trade
Apr 11, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$125k 3,751 shares
$33.36
$48.07
Alkermes plc
Alkermes plc ALKS
Director
Holding Value $652k 13,555 shares
Last Trade
Apr 11, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$30.1k 901 shares
$33.36
$48.07
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $4.23M 294,346 shares
Last Trade
Jan 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.27M 75,133 shares
$16.86
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.27M 75,133 shares
$16.86
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $182k 12,667 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$221k 12,666 shares
$17.43
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $3.15M 219,213 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$221k 12,666 shares
$17.43
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $575k 40,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$699k 40,000 shares
$17.48
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $2.97M 206,547 shares
Last Trade
Dec 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 9,300 shares
$15.11
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $3.1M 215,847 shares
Last Trade
Nov 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.48k 500 shares
$14.95
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $3.11M 216,347 shares
Last Trade
Nov 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.99k 200 shares
$14.95
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $160k 11,112 shares
Last Trade
Jul 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$123k 11,111 shares
$11.06
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $3.11M 216,547 shares
Last Trade
Jul 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$123k 11,111 shares
$11.06
$14.38
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $2.57M 178,442 shares
Last Trade
Jul 02, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$2.24M 232,021 shares
$9.66
$14.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up